Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03694145

Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Charles Drew University of Medicine and Science · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to compare the results of a deep learning approach to diabetic retinopathy assessment with results from (1) an in-person examination with an ophthalmologist, and (2) the assessments of optometrists involved in a teleretinal screening program.

Detailed description

This study represents the third aim of a grant with five aims. The study will compare and evaluate the predictive accuracy of: (a) machine learning models developed to grade diabetic retinopathy and assess the presence or absence of diabetic macular edema and (b) the assessments of optometrist readers, both from digital retinal images, against standard of care dilated retinal examinations by board-certified ophthalmologists and/or retinal-specialty fellows for 300 diabetic patients utilizing a Los Angeles County reading center. For the study, the investigators will recruit 300-500 eligible diabetic patients for in-person eye examinations performed by board certified ophthalmologists and/or retinal-specialty fellows at Los Angeles County reading centers. The study will take place over the course of two visits: a teleretinal screening and an in-person eye examination. The in-person dilated eye examinations that the study participants will participate in and be compensated for follow the usual standard of care that patients receive in a setting that does not utilize teleretinal screening. Yearly dilated eye examinations are standard of care for all persons with diabetes.

Conditions

Interventions

TypeNameDescription
OTHERIn-Person Eye ExaminationDilated in-person eye examination by a board-certified ophthalmologist or retinal fellow.

Timeline

Start date
2018-10-25
Primary completion
2025-05-31
Completion
2025-07-31
First posted
2018-10-03
Last updated
2025-02-14

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03694145. Inclusion in this directory is not an endorsement.